Breast Cancer-Therapeutic Challenges, Research Strategies and Novel Diagnostics

• Weitere Verfasser: Nabieva, Naiba (Herausgegeben von)
• Format: Elektronisch Buchkapitel
• Sprache: Englisch
• Veröffentlicht: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Schlagworte: Medicine; pannexin 1 (PANX1); neutrophils; adenosine; tumor microenvironment (TME); breast cancer; ER heterogeneity; 18F-FES PET/CT; diagnosis; treatment pattern; metastatic breast cancer; heterogeneity; HER2; 18F-fluorodeoxyglucose positron emission tomography/computed tomography; pyrotinib; therapy response; oncotype DX; recurrence score; individualized therapy; advanced breast cancer; breast cancer susceptibility genes 1 and 2; genetic testing; human epidermal growth factor receptor 2-negative; poly(adenosine diphosphate-ribose) polymerase inhibitors; real-world; machine learning; neoadjuvant systemic treatment; lymph node metastasis; phytochemicals; nanocarriers; chemotherapy; drug resistance; risk prediction models; breast cancer screening; risk assessment; risk-based screening; localization technique; non-palpable lesion; intraoperative ultrasound; wire-guided localization; magnetic seed; radioactive seed; radar reflector; radiofrequency identification tag; oncology; telemedicine; telerehabilitation; psychological well-being; cognitive impairment; rehabilitation; cancer side effects; metastasis; treatment; human epidermal growth factor receptor 2; hormone receptor; registries; endocrine treatment; CDK4/6 inhibitor; abemaciclib; dalpiciclib; palbociclib; ribociclib; Contrast-Enhanced Mammography; Digital Breast Tomosynthesis; Average Glandular Dose; TNBC; LEMD1; ERK; therapeutic target; BOUNCE; coping self-efficacy; fear of cancer recurrence; latent growth modeling; trajectories; n/a
• Online-Zugang: DOAB: download the publication; DOAB: description of the publication

Thanks to the breast cancer research of recent decades, effective methods and strategies have been established, allowing the mortality rates of breast cancer patients to decrease more and more. However, we still face many challenges. The role of certain biomarkers or mutations is still not clear for...